Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns Trump says he will spend up to $500 million of 'my money' to help Republicans in midterms How to secure edge AI in customer-owned environments | Microsoft Security Blog British army told to stop non-essential training exercises to save money Hugging Face goes from a ‘scrappy’ startup named after an emoji to $13 billion Nvidia acquisition

Herriot Tabuteau

Herriot Tabuteau

Herriot Tabuteau (#2252)

Global Rank #2252
Country Rank #764
Country United States

Herriot Tabuteau is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 2 B
  • Healthcare
  • United States
  • M
  • 58 Years

Snapshot

Quick Facts

Global Rank #2,252
Country Rank #764
Net Worth $1.8B
Previous Worth $1.9B
Worth Change -$0.1B
Country United States
Industry Healthcare
Age 58 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 28 Aug 2026, 12:00 AM
Residence New York, New York
World Billionaires List United States Billionaires Healthcare

Profile Data

Personal Stats

Age 58
Source Of Wealth Healthcare, Self Made
Self Made Score 10
Residence New York, New York
Citizenship United States
Marital Status Married
Children 2
Education Medical Doctor, Yale School of Medicine; Bachelor of Arts, Wesleyan
Net Worth Change -$0.1B -5.3% from previous worth
Previous Net Worth $1.9B
Current Net Worth $1.8B

Worth as of May 4, 2026

About Me

Herriot Tabuteau founded Axsome Therapeutics in 2012 with the goal of developing life-changing treatments for the millions of patients living with brain disorders. Tabuteau owns 15% of Axsome, which he took public in 2015. Prior to founding the company, Tabuteau worked in healthcare finance, including as a partner at hedge fund Healthco/S.A.C. Capital. He is the inventor on more than 200 patents, including potential new medicines for depression, behavior disturbances in Alzheimer's disease and narcolepsy. Axsome's drug Symbravo (meloxicam and rizatriptan) received FDA approval in January 2025 for the acute treatment of migraines with or without auras. Its drug AXS-05 for the treatment of Alzheimer's disease agitation received a Breakthrough Therapy designation from the FDA in 2020. It now plans to submit a supplemental new drug application for it.

Wealth Growth

Net Worth Growth Over Time

Tracking Herriot Tabuteau's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $1.8B (May 4, 2026)

© Iconic Billionaires